Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2024

Genmab — Januar 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    Plimsoller
    wrote on sidst redigeret af
    #1143

    @Bulder Da de også er listet i USA, så er det vel de 4 uger der trumfer Genmab's egne vedtægter (som de derfor bør ændre), og derfor gælder?

    1 Reply Last reply
    0
    • P Offline
      P Offline
      Plimsoller
      wrote on sidst redigeret af
      #1144

      Spørgsmålet om deres udmeldinger i denne periode kommer op hvert eneste år her på chatten, så nu har jeg spurgt dem inde på IR. Det vil jo i givet fald forklare hvorfor vi ikke har hørt noget.

      1 Reply Last reply
      0
      • JørgenVarnæsJ Offline
        JørgenVarnæsJ Offline
        JørgenVarnæs
        wrote on sidst redigeret af
        #1145

        Isn’t this in line with common GEN IR practise? Since Rachel left GEN has shown precious little interest (bordering to sweet FA) for retail investors.

        1 Reply Last reply
        0
        • P Offline
          P Offline
          Plimsoller
          wrote on sidst redigeret af
          #1146

          Let's see JV. If I get
          a reply I will of course share.

          1 Reply Last reply
          0
          • JørgenVarnæsJ Offline
            JørgenVarnæsJ Offline
            JørgenVarnæs
            wrote on sidst redigeret af
            #1147

            Thx

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #1148

              Dem der gerne vil have aktien, de køber alle på lukkeauktionen.

              1 Reply Last reply
              0
              • L Offline
                L Offline
                lahn1
                wrote on sidst redigeret af
                #1149

                Er der mig, eller var der liiidt styrke i aktien idag ? Vil være dejlig hvis vi kan komme i 2000 inden regnskab og få en buffer ned til 1901 når markedet bliver åhh så overraskede over ny højere omkostninger til de mange ph3 trials

                1 Reply Last reply
                0
                • W Offline
                  W Offline
                  w
                  wrote on sidst redigeret af
                  #1150

                  Kan være markedet har ændret holdning til dyre fase 3 forsøg i positiv retning,
                  efter voldgiften

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #1151

                    Mon ikke man vil nervøs indtil regnskab og specielt guidance foreligger. Man anser jo R&D for en katastrofe.

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      lahn1
                      wrote on sidst redigeret af
                      #1152

                      Jo fase 3 forsøgene er jo en nødvendighed, særligt nu da voldgiften er tabt og burde blive belønnet som et fremskridt. Gmab skal jo bare huske at highlighte deres succesrate. Så bliver det jo så godt som money in the bank 🙂 Men guidance skal helst bekræfte den fortsat kraftige vækst

                      1 Reply Last reply
                      0
                      • B Offline
                        B Offline
                        bikube
                        wrote on sidst redigeret af
                        #1153

                        Både Genmab og Novo fortsatte op i USA

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #1154

                          from
                          Scancell Interim Results for the six months ended 31 October 2023- Antibodies:
                          • Development of SC129, out licensed to Genmab, continues on track towards potential clinical
                          development.
                          https://www.scancell.co.uk/Data/Sites/1/media/publications/rns/2024/scancell-interim-results-31-october-2023.pdf

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #1155

                            Novel Cervical Cancer Treatments in Clinical Trial https://news.med.miami.edu/novel-cervical-cancer-treatments-in-clinical-trial/ “The antibody drug conjugate tisotumab vedotin-tftv has also gained approval and became a standard-of-care therapy this year. This therapy extends survival significantly,” said Dr. Sinno.

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #1156

                              Pfizer
                              earnings later today will give us full year Tiso sales

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #1157

                                Tivdak had list price changes this year of 3,90% 30-3-2023
                                and 3,90%
                                28-9-2023

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #1158

                                  so, pfizer reports $4mn for Tivdak under Represents revenues from legacy Seagen products subsequent to the acquisition on December 14, 2023. So now we have to find the remainder of the quarter 4 sales somewhere lol, Seagen doesn't report anymore

                                  1 Reply Last reply
                                  0
                                  • M Offline
                                    M Offline
                                    M_T_A
                                    wrote on sidst redigeret af
                                    #1159

                                    Pfizer skriver at FDA har accepteret Tivdak sBLA ansøgning om konvertering fra "accelerated approval" til fuld godkendelse med priority review og PDUFA dato d. 9 maj, se link side 8. 2024.https://s28.q4cdn.com/781576035/files/doc_financials/2023/q4/Q4-2023-PFE-Earnings-Release.pdf

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      lahn1
                                      wrote on sidst redigeret af
                                      #1160

                                      Håber det giver himmelfart til kursen 🙂

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        Plimsoller
                                        wrote on sidst redigeret af
                                        #1161

                                        Svar fra Andrew Carlsen angående stilleperioden "Our quiet period before earnings is still 2 weeks and has not been extended to 4 weeks with the US listing."

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #1162

                                          thanks Plimsoller

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper